Late-breaking abstract submissions are now open for #CEPAS2026!
Share your latest research with the international paediatric and neonatology
community.
Submit here: buff.ly/V4olFt2
⏳ Submission deadline: 24 June 2026
Lyon, France | 28–31 October 2026
#neotwitter
Mitra et al. conducted a comparative effectiveness research study to compare the relative effectiveness of different PDA regimens and to compare the clinical outcomes between infants treated with pharmacotherapy and those not treated.
buff.ly/JEZiU5U#EBNeoAlerts#NeoEBM
Martinez et al. conducted a post-hoc exploratory analysis of PLUSS to describe the early respiratory trajectories of infants born <26 weeks’ gestation who received surfactant during their initial NICU admission.
buff.ly/Hk697aO#EBNeoAlerts#NeoEBM
Tolia et al. conducted a natural experiment observational study comparing NEC among infants in high versus low probiotic-use centers to evaluate changes in probiotic use and NEC in preterm infants following the 2023 FDA actions.
buff.ly/mYR4KQW#EBNeoAlerts#NeoEBM
Siefkes et al Vs Mitra et al
Which publication posted by @EBNeo during May is most likely to impact your practice?
IAOTM Vote is now open on our website!
ebneo.org/vote#EBNeoPolls
The interactive programme for CEPAS 2026 is online!
Explore sessions, topics, and activities that will bring
together experts from across Europe.
buff.ly/hTW2gzv
Lyon, France, 28–31 October
Join @EBNEO in Lyon and be part of #CEPAS2026#neotwitter#neoEBM@ESPR_ESN
Deschmann et al. conducted a population-based cohort study from the Swedish Neonatal Quality Register included preterm newborns to determine the associations between phototherapy and neonatal mortality or morbidity.
buff.ly/7qoiLSy#EBNeoAlerts#NeoEBM
Mitra et al. conducted a multicentre pilot RCT to assess feasibility of recruitment and compare clinical outcomes in a trial of early selective treatment of a moderate–severe PDA or no intervention in extremely preterm infants.
buff.ly/8mIuzF0#EBNeoAlerts#NeoEBM
Shridhar et al. conducted a randomized controlled trial in late preterm and term neonates requiring phototherapy to compare the rate of bilirubin decline between intermittent and continuous phototherapy.
buff.ly/gtspEGo
Rasmussen Vs. Devlin:
Which RCT posted by @EBNeo during April is most likely to impact your practice?
Vote is now open for our #IAOTMebneo.org/vote#EBNeoPolls
Once the glow from @PASMeeting wears off, start planning your next conference and join us for #CEPAS2026 in Lyon, France October 28th - 31st. @EBNEO will be there highlighting neonatal clinical research. Join us and @ESPR_ESN!
Register here: buff.ly/R6VD3JG
Announcing the EBNEO Impact Article of the Year for 2025:
Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants
The PDA Randomized Clinical Trial by Laughon et al for the NICHD NRN
jamanetwork.com/journals/jam…#EBNEO#IAOTY2025#neoEBM
Minor correction to the conclusions - it reduced the time to medical readiness for discharge for the ESC cohort, and 65% in the symptoms-based group avoided scheduled tapers.